The New Power of the Pharmaceutical Industry: Covid-19 Vaccines and Social Responsibility

"Pricing and distribution of Covid-19 vaccines can intensify global and social inequality," argues business ethicist based in Austria in a recent publication.
By: PR&D
VIENNA - Nov. 5, 2020 - PRLog -- The initial scarcity of effective vaccines against Covid-19 entails an enormous social responsibility to the producing pharmaceutical companies. If the pricing and distribution of this scarce health resource were to be based exclusively on traditional market principles, rich countries and members of the upper class would be protected earlier than poorer ones. This would further manifest global and social inequality. This is the basic thesis of an article now published by the Head of the Institute for Business Ethics and Sustainable Strategy (IBES) at FHWien der WKW (University of Applied Sciences for Management & Communication) in Austria, who also proposes three concrete measures for ensuring a fair and just allocation of vaccines.

Original publication:

Scholz, M: The social responsibility of pharmaceutical companies for the production, pricing and allocation of Covid-19 vaccines. In Alexander Brink, Bettina Hollstein, Christian Neuhäuser, Marc C. Hübscher (eds.): Lessons from Corona, Impulses from Business and Corporate Ethics, 1st edition, 2020, pp. 215-226.

Dr. Till C. Jelitto
Email:*** Email Verified
Tags:Covid-19 Vaccine
Location:Vienna - Vienna - Austria
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share